ARCHIVES

MDV3100 Improves Survival, Reduces Death Risk by 37%

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Weight An Indicator For Risk Of Developing Myeloma

August 31, 2007

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

Lenalidomide Maintenance Increased PFS and Survival

May 25, 2012

MRI Contract: AACI Group Still Seething

August 8, 1986

NIH Plans Conference On DCIS Diagnosis, Management

July 17, 2009

ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention

November 16, 1979